FOXC1: A Specific Biomarker for Triple Negative Breast Cancer Diagnosis and Classification

被引：0
|
作者：
Li, Ming [1 ]
Lv, Hong [1 ]
Zhong, Siyuan [1 ]
Zhou, Shuling [1 ]
Li, Anqi [1 ]
Lu, Hongfen [1 ]
Yang, Wentao [1 ]
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
来源：
LABORATORY INVESTIGATION | 2021年 / 101卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
107
引用
收藏
页码：122 / 123
页数：2
相关论文
共 50 条
  • [21] The clinicopathologic significance of FOXC1 in BRCA-mutant breast cancer.
    Choi, Michael Phillip
    Cui, Xiaojiang
    Dadmanesh, Farnaz
    Liles, Georgia
    Zhang, Xiao
    Karlan, Beth
    Glullano, Armando E.
    Amersi, Farin F.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [22] VPAC1 biomarker for imaging triple negative breast cancer
    Tripathi, Sushil
    Kumar, Pardeep
    Jin, YuanYuan
    Wickstrom, Eric
    Thakur, Mathew
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [23] Erratum to: FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells
    Juan Du
    Lin Li
    Zhouluo Ou
    Chenfei Kong
    Yu Zhang
    Zhixiong Dong
    Shan Zhu
    Hao Jiang
    Zhimin Shao
    Baiqu Huang
    Jun Lu
    Breast Cancer Research and Treatment, 2016, 156 : 609 - 610
  • [24] Evaluation of FOXC1 as a therapeutic target for basal-like breast cancer
    Mott, Landon
    Su, Kai
    Pack, Daniel W.
    CANCER GENE THERAPY, 2018, 25 (3-4) : 84 - 91
  • [25] Molecular classification of triple negative breast cancer
    Lehmann, Brian D.
    Bauer, Josh A.
    Chen, Steven
    Shyr, Yu
    Sanders, Melinda
    Pietenpol, Jennifer A.
    FASEB JOURNAL, 2013, 27
  • [26] FOXC1-induced LINC01123 acts as a mediator in triple negative breast cancer
    Zhang, Purong
    Long, Qimin
    Zeng, Shiyan
    Wen, Min
    Lu, Qing
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [27] FOXC1-induced LINC01123 acts as a mediator in triple negative breast cancer
    Purong Zhang
    Qimin Long
    Shiyan Zeng
    Min Wen
    Qing Lu
    Cancer Cell International, 20
  • [28] FOXC1: an emerging marker and therapeutic target for cancer
    B Han
    N Bhowmick
    Y Qu
    S Chung
    A E Giuliano
    X Cui
    Oncogene, 2017, 36 : 3957 - 3963
  • [29] FOXC1 is associated with estrogen receptor and affects sensitivity of tamoxifen treatment in breast cancer
    Wang, Jin-hua
    Xu, Ya-li
    Chen, Xiu-ping
    Li, Li
    Wang, Lin
    Yao, Ru
    Sun, Qiang
    Du, Guan-hua
    ACTA PHARMACOLOGICA SINICA, 2017, 38 (07) : 1079 - 1080
  • [30] FOXC1: an emerging marker and therapeutic target for cancer
    Han, B.
    Bhowmick, N.
    Qu, Y.
    Chung, S.
    Giuliano, A. E.
    Cui, X.
    ONCOGENE, 2017, 36 (28) : 3957 - 3963
12345